IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 141 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.41 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,325 | +18.0% | 216,782 | +23.3% | 0.13% | -5.8% |
Q4 2022 | $1,123 | -99.9% | 175,793 | +117.6% | 0.14% | +35.0% |
Q3 2022 | $774,000 | -60.8% | 80,776 | -54.8% | 0.10% | -65.2% |
Q2 2022 | $1,972,000 | +604.3% | 178,578 | +961.5% | 0.30% | +678.9% |
Q1 2022 | $280,000 | -4.8% | 16,823 | +9.3% | 0.04% | +2.7% |
Q4 2021 | $294,000 | +19.0% | 15,398 | +189.4% | 0.04% | -7.5% |
Q4 2020 | $247,000 | +81.6% | 5,321 | -62.7% | 0.04% | +185.7% |
Q1 2019 | $136,000 | -43.1% | 14,266 | -47.2% | 0.01% | -50.0% |
Q4 2018 | $239,000 | – | 27,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |